<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Hypocalcemia":3,
"Hypoparathyroidism":4,
"Pediatric population":1,
"Total thyroidectomy":3,
"Extrathyroidal extension":7,
"thyroid cancer":71,
"thyroidectomy":19,
"APC":1,
"Cribriform-morular":1,
"Cribriform-morular variant papillary thyroid carcinoma":1,
"FAP":1,
"Familial adenomatous polyposis":1,
"Thyroid carcinoma":21,
"Wnt":1,
"β-catenin":1,
"Childhood cancer survivors":1,
"Cyclophosphamide":1,
"Endocrine late effects":1,
"Hematopoietic stem cell transplantation":1,
"Radiation therapy":2,
"BAVANS":1,
"Lymph node dissection":3,
"Video-assisted neck surgery":1,
"diagnosis":13,
"gastric cancer":4,
"lncRNA PTCSC3":1,
"prognosis":31,
"BRAF gene":3,
"Lymph node metastasis (LNM)":2,
"PAQR3":1,
"Papillary thyroid microcarcinoma":4,
"preconception planning":1,
"pregnancy":3,
"thyroid nodules":6,
"3,5,3′-Triiodo-L-thyronine (T3)":1,
"Degranulation":1,
"Integrin":1,
"L-Thyroxine (T4)":2,
"Metastasis":10,
"Thyroid hormone receptors":1,
"Tumor cell invasiveness":1,
"Korea":1,
"mass screening":1,
"mortality":4,
"thyroid neoplasms":29,
"ultrasonography":15,
"contralateral thyroid lobe":1,
"lobectomy":3,
"nodules":1,
"papillary thyroid carcinoma":70,
"ultrasound":12,
"TIRADS":1,
"risk stratification":2,
"small thyroid nodules":1,
"thyroid carcinomas":1,
"Biomarkers":3,
"Papillary thyroid cancer":23,
"Patient stratification":1,
"Tumor progression":1,
"ear, nose and throat/otolaryngology":1,
"head and neck surgery":2,
"otolaryngology/ENT":1,
"thyroid disease":2,
"INI1":1,
"Metastatic cancer":1,
"Rhabdoid":1,
"SMARCB1":1,
"Colorectal cancer":2,
"ablation":2,
"liver metastasis":2,
"resection":1,
"simultaneous treatment":1,
"PEI":1,
"nodule":1,
"nodulus":1,
"sclerotherapia":1,
"sclerotherapy":1,
"thyreoidea":1,
"thyroid":24,
"FAT1":1,
"FAT4":1,
"copy number alteration":1,
"molecular subtype":1,
"multi-omics profiling":1,
"sporadic medullary thyroid carcinoma":2,
"CAT":1,
"GPX":1,
"MnSOD":1,
"polymorphism":1,
"Clinical research":1,
"Fibroblast growth factor receptor":1,
"Lenvatinib":4,
"Molecular biology":2,
"anastomosis":1,
"cabozantinib":2,
"medullary thyroid carcinoma":23,
"tyrosine kinase inhibitors":2,
"FOXC1":1,
"Hepatocellular carcinoma":2,
"TRIP6":1,
"lymph nodes metastases":1,
"recurrence":11,
"response to therapy":1,
"Bioelectrical impedance analysis":1,
"Weight loss":1,
"antiresorptive treatment":1,
"bone metastasis":1,
"medullary thyroid cancer":5,
"skeletal-related adverse events":1,
"American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS)":1,
"The Bethesda System for Reporting Thyroid Cytopathology":1,
"fine-needle aspiration (FNA)":2,
"risk of malignancy":1,
"thyroid cytology":2,
"Fine-needle aspiration":7,
"Neoplasm":2,
"Thyroid Imaging Reporting And Data System":2,
"delphian lymph node":1,
"lymph node metastasis":14,
"tumor":2,
"Free flap":1,
"Immediate reconstruction":1,
"Locoregional recurrence":2,
"Postmastectomy radiation therapy":1,
"rat hepatocyte":1,
"sirtuin":1,
"thyroid hormone":4,
"thyronamine":1,
"BRAF":8,
"Follicular variant of papillary thyroid carcinoma":2,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"RAS":6,
"Cell cycle":3,
"Cell proliferation":1,
"HTR3A":1,
"miR-1256":1,
"calcitonin":6,
"carcinoembryonic antigen":1,
"neuron-specific enolase":1,
"Lateral neck lymph node metastasis":1,
"advanced thyroid cancer":1,
"distant metastasis":5,
"genetic profile":1,
"next generation sequencing":1,
"Antithyroid drugs":1,
"Chronic hepatitis C":1,
"Hyperthyroidism":2,
"Hypothyroidism":8,
"Thyroid autoimmunity":1,
"Distant metastases":1,
"FT-UMP":1,
"MI-FTC":1,
"Radioiodine therapy":4,
"WDT-UMP":1,
"RET":3,
"association study":1,
"haplotype":1,
"polymorphisms":1,
"Next-generation DNA sequencing":1,
"RET protooncogene":1,
"HOST2":1,
"Let-7b":1,
"STAT3":1,
"TNBC":2,
"ceRNA":1,
"AUS":1,
"FLUS":1,
"FNA":2,
"nuclear atypia":1,
"Anaplastic thyroid carcinoma":9,
"Clinical practice guidelines":2,
"Follicular thyroid carcinoma":8,
"Electrochemiluminescence immunoassay (ECLIA)":1,
"Radioimmunoassay (RIA)":1,
"BAG5":1,
"Fibronectin 1":1,
"anatomic landmarks":1,
"clinical applied anatomy":1,
"endoscopic thyroidectomy":3,
"technical":1,
"Artificial neural network":1,
"Follicular neoplasm":3,
"Machine learning":2,
"Support vector machine":2,
"Cardiovascular disease":1,
"Hyperlipidemia":1,
"Hypertension":1,
"Medicare":1,
"Nonalcoholic fatty liver disease":1,
"Outcomes":1,
"Resource utilization":1,
"Trends":2,
"Type 2 diabetes":2,
"GA binding protein transcription factor alpha":1,
"hypoxia-inducible factor 1α":1,
"lysine-specific demethylase 1":1,
"microRNA-146a":1,
"transcription factor":4,
"Autophagy":3,
"mTOR":3,
"Microscopic margin":1,
"Radioactive iodine treatment":1,
"Treatment response":1,
"ETS variant 5":1,
"Epithelial-mesenchymal transition":4,
"Estrogen receptor":2,
"PIK3CA":2,
"endoscopic parathyroidectomy":1,
"minimally invasive surgery":1,
"remote access surgery":1,
"transoral endocrine surgery":2,
"transoral parathyroid surgery":1,
"transoral thyroid surgery":1,
"Adult":4,
"Case report":14,
"Magnetic resonance imaging":6,
"Pathology":2,
"Pituitary blastoma":1,
"Alzheimer disease":1,
"Anterior callosal angle":1,
"Callosal angle":1,
"Idiopathic normal pressure hydrocephalus":1,
"Advanced thyroid carcinoma":1,
"Proteinuria":1,
"UPCR":1,
"malignancy risk":1,
"thyroid malignancy":1,
"thyroid nodule":16,
"thyroid nodule size":1,
"BHLHE40":1,
"Cellular senescence":1,
"DEC1":1,
"Prostate cancer":2,
"Nomogram":4,
"Renal cell carcinoma":3,
"SEER":3,
"Sarcomatoid":1,
"Computed tomography":1,
"lymphoma":3,
"synchronous malignancy":1,
"Clear cell renal cell carcinoma":1,
"Epigenetics":1,
"Prognostic signature":1,
"Survival analysis":2,
"m6A methylation":1,
"Ovarian Sertoli-Leydig cell tumors":1,
"Slcts":1,
"Deiodination":1,
"FT3/FT4":1,
"Refractory disease":1,
"Regorafenib":1,
"Survival":8,
"COVID-19":4,
"head and neck advocacy":1,
"head and neck cancer support":1,
"not-for-profit":1,
"AR pathway":1,
"Hormone":2,
"PI3k/Akt pathway":2,
"Sertoli cell":1,
"Spermatogenesis":1,
"cAMP/PKA pathway":1,
"Papillary carcinoma of the thyroid":1,
"Bioinformatics":5,
"N(6)-methyladenosine":1,
"The Cancer Genome Atlas":2,
"Colitis":1,
"Diabetes":1,
"Hypophysitis":1,
"Immune checkpoint inhibitors":1,
"Pneumonitis":1,
"Thyroid disorders":1,
"Carcinoma papilar de tiroides":1,
"Cirugía radioguiada":1,
"Radioguided surgery":1,
"Recurrencia cervical":1,
"Recurrent cervical cancer":1,
"low risk":1,
"therapy":2,
"Adolescent":2,
"Cancer":8,
"Childhood":1,
"Incidence":3,
"Netherlands":1,
"Stage at diagnosis":1,
"Leukocytosis":1,
"Paraneoplastic syndrome":1,
"BRAFV600E mutation":2,
"NIFTP":8,
"follicular variant of papillary thyroid cancer":1,
"radioactive iodine therapy":4,
"indeterminate cytology":1,
"molecular diagnostics":1,
"personalized healthcare":1,
"variant detection":1,
"head and neck cancer":5,
"head and neck squamous cell carcinoma":4,
"salivary gland cancer":1,
"skin cancer":1,
"IGF-1":2,
"IGF-1R":1,
"angiogenesis":2,
"breast cancer":10,
"lncRNA NR2F1-AS1":1,
"Sutton naevus":1,
"melanoma-associated hypopigmentation":1,
"neuroendocrine tumour":2,
"vitiligo":1,
"halo naevus":1,
"hőablatio":1,
"pajzsmirigygöb":1,
"radiofrequency ablation":2,
"rádiófrekvenciás ablatio":1,
"thermal ablation":2,
"ultrahang":1,
"HOTAIR":1,
"lncRNA":2,
"131I radioiodine":1,
"differentiated thyroid cancer":6,
"maximum permissible dose":1,
"radiation effective dose":1,
"Abemaciclib":1,
"CDK4/6 inhibitor":1,
"DOCK180":1,
"JAK/STAT/AMPK":1,
"invasion":4,
"migration":6,
"proliferation":6,
"Hepatic hilar plate":1,
"Hepatic resections":1,
"Liver anatomy":1,
"Liver neoplasms":1,
"Hashimoto's thyroiditis":4,
"familial hypocalciuric hypercalcaemia":1,
"follicular variant papillary thyroid carcinoma":2,
"primary hyperparathyroidism":5,
"papillary":3,
"tumor stem cells":1,
"Cardiac rupture":1,
"Cardiopulmonary resuscitation":1,
"Neoadjuvant chemotherapy":1,
"Physiotherapy":1,
"Thymoma":2,
"Alberta":1,
"Canada":1,
"Demographics":1,
"Epidemiology":3,
"Survivors":1,
"Survivorship":2,
"apoptosis":5,
"integrin αvβ3":1,
"tetraiodothyroacetic acid (tetrac)":1,
"radiomics":3,
"M918T mutation":2,
"RET proto-oncogene":6,
"Thyroid neoplasm":2,
"mixed medullary-follicular carcinoma":1,
"multiple endocrine neoplasia type 2B":1,
"PHTS":1,
"PTEN":2,
"Virchow–Robin spaces":1,
"cMRI":1,
"children":1,
"enlarged perivascular spaces":1,
"macrocephaly":1,
"white matter abnormalities":1,
"BRAF mutation":3,
"HMGB1":1,
"Vemurafenib":1,
"Child":1,
"Surgical procedures, operative":1,
"Hürthle cell carcinoma":2,
"SETD2 loss-of-function mutations":1,
"poorly differentiated thyroid cancer":2,
"Follicular thyroid cancer":1,
"Oncocytic/oxyphilic follicular carcinoma":1,
"Radioablation":1,
"Anaplastic carcinoma":2,
"Immunohistochemistry":9,
"Well-differentiated carcinoma":1,
"Adenoma":1,
"Gallbladder":1,
"Preinvasive neoplasm":1,
"Pyloric":1,
"Tubular&nbsp":1,
"Renal cell carcinoma (RCC)":1,
"targeted drugs":1,
"thyroid function":1,
"Small-cell lung cancer (SCLC)":1,
"durvalumab":2,
"immunotherapy":5,
"third-line treatment":1,
"Dedifferentiated chondrosarcoma":1,
"Differential diagnosis":2,
"Bone metastases":2,
"Bone mineral density":2,
"Differentiated thyroid carcinoma":7,
"Fractures":1,
"Levothyroxine":3,
"TSH suppression":1,
"BRAFV600E":6,
"TERT promoter":2,
"TP53":1,
"Doubling rate":1,
"Kinetic analysis of the growth rate":1,
"Tumor volume":1,
"Biomarker":5,
"Chemotherapy sensitivity":1,
"Lung neoplasms":1,
"TTF-1":2,
"Lung":2,
"Meta-analysis":5,
"Metastatic":2,
"PAX8":2,
"Primary":1,
"dexamethasone":1,
"microgravity":1,
"space environment":1,
"low-risk thyroid cancer":1,
"shared decision making":1,
"thyroid lobectomy":2,
"PDGF":1,
"Vit D":1,
"age period cohort":1,
"epithelial cancer":1,
"sex ratios":1,
"Laryngeal carcinoma":1,
"Malignancy larynx":1,
"Thyroid invasion":1,
"Lymphatic metastasis":5,
"Papillary thyroid carcinoma (PTC)":5,
"Tumour location":1,
"erlotinib":1,
"non-small cell lung cancer":3,
"p63":1,
"prediction":1,
"prognostic":1,
"thyroid transcription factor one":1,
"biological characteristics":1,
"contrast-enhanced ultrasound":4,
"risk factors for prognosis":1,
"PDK-1":1,
"p-Akt":1,
"sPD-L1":1,
"childhood and adolescence":1,
"iodine-131":2,
"long-term complications":1,
"second primary malignancy":1,
"young females":1,
"EZH2":1,
"LOXL4":1,
"Macrophage":2,
"miR-29b/miR-30d":1,
"thyroglobulin antibodies":1,
"miR-34a":1,
"clinical application":1,
"linc-ROR":1,
"long noncoding RNA":1,
"mechanisms":1,
"CT":1,
"MRI":3,
"ectopic thyroid":2,
"multimodality":1,
"thyroid scintigraphy":1,
"secondary tumor":1,
"thyroid gland":4,
"tumor biology":1,
"brachioradialis":1,
"flexor digitorum superficialis":1,
"posterior pharyngeal wall":1,
"radial forearm free flap":1,
"soft tissue necrosis":1,
"Ex, extrathyroidal extension":1,
"PTC, papillary thyroid carcinoma":1,
"Positive extrathyroidal extension":1,
"Prophylactic lateral neck dissection":1,
"RAI, radioactive iodine":2,
"RFS, recurrence free survival":1,
"pLND, Prophylactic lateral neck dissection":1,
"cancer stem cells":1,
"epiblast":1,
"human embryonic stem cells":1,
"human induced pluripotent stem cells":1,
"oncogenesis":2,
"organoids":1,
"reprogram enablement":1,
"reprogramming":1,
"MEN 1 gene":1,
"RET gene":1,
"multiple endocrine neoplasia type 1":1,
"multiple endocrine neoplasia type 2":3,
"PTC":2,
"dermatologic surgery":1,
"ethanol injection":1,
"long-term prognosis":1,
"skin metastasis":1,
"neuropsychiatric":1,
"psychosis":1,
"BGC-823 cells":1,
"Gastric neoplasms":1,
"MiR-141-3p":1,
"NF-κB signaling pathway":1,
"long non-coding RNA":5,
"messenger RNA":1,
"microRNA":3,
"brain metastasis":1,
"surgical resection":1,
"FANCA gene":1,
"literature review":1,
"multiple primary malignancy":1,
"CT, computed tomography":1,
"Cavernous hemangioma":1,
"FLAIR, fluid attenuation inversion recovery":1,
"GRE, gradient echo sequences":1,
"Intracranial hemorrhagic metastasis":1,
"MRI, magnetic resonance imaging":1,
"SWI, susceptibility-weighted imaging":1,
"RCAS1":1,
"thyroidbiomarkers":1,
"thyroidcancer":1,
"thyroidneoplasm":1,
"Endocrine":3,
"I-131 therapy":1,
"Oncology: Endocrine":1,
"Radionuclide Therapy":1,
"tumor thrombus":1,
"acute myeloid leukemia":1,
"immunomodulatory drugs":1,
"lenalidomide":1,
"pomalidomide":1,
"thalidomide":1,
"Familial papillary thyroid cancer":1,
"Outcome":2,
"Recurrences":1,
"Sporadic papillary thyroid cancer":1,
"Conversion surgery":1,
"Peritoneal dissemination":1,
"Breast neoplasms":3,
"Circulating tumor DNA":1,
"Neoadjuvant therapy":1,
": Multiple endocrine neoplasia type 2B":1,
"Chinese":1,
"extra-endocrine signs":1,
"Cancer survivors":2,
"Conformal":1,
"Radiotherapy":3,
"Radiotherapy dosage":1,
"NTRK gene rearrangement":1,
"cytomorphology":1,
"Fibronectin-1":1,
"Ursolic acid":1,
"Case-report":1,
"Congenital digestive system abnormalities":1,
"Hirschsprung disease":2,
"Neurocristopathy":1,
"REarranged during Transfection":1,
"Pectoralis muscle":1,
"trachea":1,
"risk factors":7,
"AHNAK2":1,
"diagnostic biomarker":2,
"immune infiltration":1,
"prognostic biomarker":1,
"anal carcinoma":1,
"biliary adenocarcinoma":1,
"cervical carcinoma":1,
"endometrial carcinoma":1,
"mesothelioma":1,
"neuroendocrine tumors":2,
"salivary gland carcinoma":1,
"small-cell lung carcinoma":1,
"vulvar carcinoma":1,
"Central lymph node metastasis":3,
"Cell movement":1,
"Dipeptidyl peptidase-IV inhibitors":1,
"NF-E2 transcription factor":1,
"Neoplasm invasiveness":1,
"Axillary approach":1,
"Surgical procedures, minimally invasive":2,
"TGF-β1":1,
"aerosolized":1,
"radiation induced lung fibrosis":1,
"Level Ⅵ":1,
"Paratracheal neck dissection":1,
"Upper limit of paratracheal neck dissection":1,
"SEER program":1,
"age":3,
"lymph node ratio":2,
"immunoassay":1,
"procalcitonin":1,
"reflex test":1,
"Thyroid hemiagenesis":1,
"Body mass index":2,
"capsular invasion":3,
"thyroid isthmus nodule":1,
"MEN2A":1,
"MEN2B":1,
"ganglioneuromatosis":1,
"gastrointestinal symptoms":1,
"multiple endocrine neoplasia":2,
"quality of life":2,
"paediatric patient":1,
"short stature":1,
"MEN 2b":1,
"Autoimmune polyendocrinopathy":1,
"auto-immune diabetes":1,
"thyroiditis":1,
"Classification":1,
"Clinical decision-making":2,
"Mutation":2,
"Parathyroid adenoma":3,
"Thyroid adenoma":1,
"M2-like TAMs":1,
"Wnt1":1,
"Wnt3a":1,
"tumor dedifferentiation":1,
"Metastases to adrenal glands":1,
"Thyroid cancer metastasis":1,
"vascular endothelial growth inhibitor":1,
"adaptive radiotherapy":1,
"dosimetric comparative study":1,
"intensity-modulated radiotherapy":2,
"nasopharyngeal carcinoma":2,
"proton beam therapy":1,
"Cricohyoidoepiglottopexy":1,
"Mucosal defects":1,
"Supracricoid partial laryngectomy":1,
"Thyroid gland flap":1,
"Wound infection":1,
"Defensive medicine":1,
"Healthcare system":1,
"Medical practice":1,
"Oversimplifying":1,
"Overtreatment":1,
"Diagnostic pitfall":1,
"Hyalinizing trabecular tumor":1,
"Immunocytochemistry":1,
"Molecular testing":1,
"PAX8/GLIS 1-3 rearrangement":1,
"Cancer survival analysis":1,
"lincRNA":1,
"non-coding RNA":1,
"pseudogene":1,
"Anthropogenic radionuclides":1,
"Biogeochemical optimum":1,
"Endemic diseases of geochemical origin":1,
"Health risk maps":1,
"Iodine":3,
"Radiation":1,
"Cribriform-morular papillary carcinoma":1,
"Ectopia":1,
"Lingual thyroid":1,
"Thyroglossal duct carcinoma":1,
"Colombia":1,
"Geographical difference":1,
"South Korea":2,
"Turkey":1,
"Masson's tumor":1,
"clivus":1,
"intravascular papillary endothelial hyperplasia":1,
"petrous bone":1,
"psammoma bodies":1,
"Genetic diseases":1,
"Genetics":2,
"Oncology":4,
"RNA processing":1,
"Foxp3":1,
"Treg":1,
"Endocrine surgery":2,
"General surgery":1,
"Thyroglossal duct cyst":1,
"airway":1,
"laryngoplasty":1,
"rhTSH":1,
"Ultrasound-based TI-RADS classification":1,
"shear wave elastography":2,
"Health-related quality of life":1,
"Downstaging":1,
"Prevalence":1,
"TNM-8":1,
"WHO 2017":1,
"Otolaryngology":1,
"Robotic platform":1,
"Robotic surgery":1,
"Technology":1,
"Transoral robotic surgery":1,
"chemoradiation":2,
"chemotherapy":1,
"national cancer data base":1,
"BRAF- and RAS-like signaling":1,
"CAFs":1,
"senescent cells":1,
"Thyroid Imaging and Reporting Data System":1,
"malignancy risk stratification":1,
"thyroid ultrasonography":1,
"overall survival":3,
"subcellular localization":1,
"thyroid hormone receptor beta 1":1,
"Asia":1,
"International cooperation":1,
"Oceania":1,
"Radiology":1,
"Screening":1,
"Biopsy, fine-needle":3,
"Cytology":6,
"Frozen sections":1,
"Poorly differentiated thyroid carcinoma":2,
"competitive endogenous RNAs network":1,
"esophageal squamous cell carcinoma":1,
"weighted gene co-expression network analysis":1,
"adverse effects":1,
"childhood cancer":1,
"fertility":1,
"radioiodine":6,
"Follicular thyroid adenoma":2,
"ROC curve analysis":1,
"Real-time PCR":1,
"thyroid cancer subtypes":1,
"2020":3,
"Female":3,
"Gynaecology":1,
"March":1,
"Unique/unexpected symptoms or presentations of a disease":2,
"White":2,
"hyperthyreosis":1,
"hypophysis adenoma":1,
"hypophysisadenoma":1,
"hypophysisműtét":1,
"pituitary surgery":1,
"collagen protein":1,
"fibrosis":1,
"platelet-derived growth factor":1,
"Adsorption":1,
"Ag(2)O":1,
"Controlled-transforming":1,
"Heterostructured framework":1,
"complications":2,
"elderly patients":1,
"geriatric":1,
"surgery":3,
"Thyroid transcription factor 1 (TTF-1)":1,
"lung adenocarcinomas":1,
"pemetrexed":1,
"Bone":2,
"Fat":1,
"Intraosseous lipoma":1,
"Plasmacytoma":1,
"oncoplastic thyroid surgery":1,
"remote access thyroidectomy":1,
"transoral thyroidectomy":3,
"AKT":1,
"angiopoietin-like 4":1,
"FSTL1":1,
"hsa_circ_0011290":1,
"miR-1252":1,
"Central neck lymph node dissection":1,
"Bethesda system":2,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"Risk of malignancy (ROM)":1,
"Ectopic":1,
"Parathyroid carcinoma":2,
"Pericardium":1,
"Bilateral disease":1,
"Risk factor":1,
"AZD8055":1,
"SNHG3":2,
"DAPK":1,
"DNA methylation":3,
"Incidental findings":1,
"Malignancy":2,
"SPECT-CT":1,
"Sestamibi":1,
"miR-146b-5p":1,
"smad4":1,
"AKT/mTOR/HK2":1,
"ANP32E":1,
"Glycolysis":1,
"papillary tumour":1,
"pituitary gland":1,
"sella":1,
"cytopathology":2,
"molecular diagnostic techniques":1,
"thyroglobulin":3,
"accessory nerve":1,
"neck dissection":8,
"neck metastasis":1,
"sublevel IIb":1,
"cervical lymph node metastasis":1,
"level 1b":1,
"oral squamous cell carcinoma":1,
"submandibular gland":1,
"iodination of salt":1,
"treatment":4,
"Intraoperative neuromonitoring":1,
"Superior laryngeal nerve":1,
"Transoral endoscopic thyroidectomy":1,
"Vestibular approach":1,
"Adrenal":1,
"Biopsy":2,
"Breast cancer*":1,
"CT scan":1,
"Chromogranin A":1,
"Cytokeratins*":1,
"DIPNECH*":1,
"Dyspnoea":1,
"Haematoxylin and eosin staining":1,
"Histopathology":2,
"May":1,
"Molecular genetic analysis":1,
"New disease or syndrome: presentations/diagnosis/management":1,
"PET scan":1,
"Paraganglioma":1,
"Portugal":1,
"Pulmonary biopsy*":1,
"Resection of tumour":1,
"S-100 protein*":1,
"Synaptophysin":1,
"Thyroxine (T4)":1,
"Wheezing":1,
"miR-155-5p":1,
"thyroid follicular carcinoma":1,
"Spinal dumbbell tumor":1,
"thyroid dysgenesis":1,
"Epidermal growth factor receptor":1,
"Fucosyltransferase VII":1,
"Glycosylation":1,
"Biopsy, fine needle":1,
"Guideline":2,
"Thyroid cancer, papillary":2,
"mitochondria":1,
"mitochondria-eating protein":1,
"mitophagy":1,
"oncocytic cell tumor":1,
"J-kindred":1,
"early thyroidectomy":1,
"multiple endocrine neoplasia 2A":1,
"prophylactic thyroidectomy":1,
"Vitamin D deficiency":1,
"Central compartment":1,
"Lymph node metastases":2,
"Metabolic imbalance":1,
"Metabonomics":1,
"Parthenolide":1,
"131I therapy":1,
"Pediatric patients":1,
"Rapamycin":1,
"Resveratrol":1,
"Xenograft":1,
"Nuclear versus cytoplasmic":1,
"Ovarian cancer":1,
"Thyroid hormone receptor":1,
"Chromosomal translocation":1,
"FOXP1":1,
"MALT lymphoma":1,
"Thyroid lymphoma":1,
"t(3":1,
"14)(p14 1":1,
"q32)/FOXP1-IGH":1,
"C-cell dedifferentiation":1,
"CA 19 9":1,
"CD133":1,
"MEN2":2,
"Femur":1,
"Macrofollicular variant of papillary thyroid carcinoma":1,
"DTC":1,
"I-131":1,
"RAI":1,
"UCA1":1,
"regulatory mechanism":1,
"Autoimmunity":1,
"Gender":1,
"Hormones":1,
"Immune checkpoint":2,
"Tfh cells":1,
"ERK signaling":1,
"interleukin-34":1,
"thyrotropin suppressive therapy":1,
"trabecular bone score":1,
"diffusion magnetic resonance imaging":1,
"feasibility studies":1,
"nomograms":1,
"Deep neural networks":1,
"Dual energy CT":1,
"Spectral CT":1,
"Texture analysis":1,
"Thyroid cartilage invasion":1,
"Diagnostic Imaging":1,
"Head And Neck Neoplasms":2,
"Squamous Cell Carcinoma Of Head And Neck":1,
"Hashimoto disease":1,
"Macrophages":1,
"T-lymphocytes":1,
"amide proton transfer (APT)":1,
"differentiation":1,
"diffusion-weighted imaging (DWI)":1,
"predominantly solid thyroid adenomatous nodule":1,
"Allergic acute tubulointerstitial nephritis":1,
"Tyrosine kinase inhibitor":2,
"Vandetanib":1,
"salivary glands":1,
"sialadenitis":2,
"xerostomia":1,
"CTLA4":1,
"PD-1":1,
"PD-L1":2,
"PD-L2":1,
"Aggressive papillary thyroid carcinoma":1,
"Diagnostic markers":1,
"Receiver operating characteristic curve":1,
"microRNA-221/222":1,
"qRT-PCR":1,
"Epidermal growth factor receptor (EGFR) mutation":1,
"endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and biopsy (FNB)":1,
"lung adenocarcinoma":1,
"pancreatic ductal carcinoma":1,
"RNA RP11-480I12 5":1,
"Hurthle cell":1,
"melanoma":2,
"skin neoplasm":1,
"Cancer management":1,
"Metastatic disease":1,
"Skeletal-related event":1,
"Body constitution":1,
"Clinical study":1,
"Medicine, Chinese traditional":1,
"Review":2,
"AUS/FLUS":1,
"RoM":1,
"atypia of undetermined significance":1,
"fine needle aspiration":1,
"SEER database":1,
"adjuvant radiation":1,
"external beam radiation":1,
"Anaplastic transformation":1,
"Intestinal perforation":1,
"Peritoneal metastasis":1,
"Metastases":2,
"Halszysten":1,
"Lymphknoten-Tuberkulose":1,
"Lymphom":1,
"Schilddrüsenknoten":1,
"Speicheldrüsen-Tumoren":1,
"Thyroid nodes":1,
"Veränderungen der Tonsillen":1,
"cervical cysts":1,
"changes in the tonsils":1,
"lymph node tuberculosis":1,
"salivary gland tumors":1,
"HDL ant-oxidative capacity":1,
"HDL cholesterol":1,
"HDL subfractions":1,
"cholesterol efflux capacity":1,
"nuclear magnetic resonance":1,
"TCGA":1,
"prognostic markers":1,
"stemness":1,
"Ankylosing spondylitis":1,
"Anti-phospholipid syndrome":1,
"Autoimmune hemolytic anemia":1,
"Idiopathic thrombocytopenic purpura":1,
"IgA nephropathy":1,
"Multiple sclerosis":2,
"Polyarteritis nodosa":1,
"Polymyositis":1,
"Sarcoidosis":2,
"Temporal arteritis":1,
"microarray analysis":1,
"siRNA":1,
"laryngeal neoplasms":2,
"multicentric study":1,
"paraglottic space":1,
"total laryngectomy":1,
"tumor thickness":1,
"Clinical prognostic model":1,
"Metastatic epidural spinal cord compression":1,
"Carcinoma de tiroides":1,
"Linfadenectomía":1,
"Lymphadenectomy":1,
"Metástasis linfática":1,
"OSNA":1,
"drug utilization":1,
"process assessment":1,
"Oral semaglutide":1,
"clinical practice":1,
"glucagon-like peptide-1 receptor agonist":1,
"guidelines":1,
"primary care":1,
"3D culture":1,
"Anaplastic thyroid cancer":2,
"Collagen":1,
"MT1-MMP":1,
"August":1,
"Israel":1,
"Other":1,
"NF-E2-related factor 2":1,
"goiter":2,
"microRNAs":2,
"vascular endothelial growth factor A":1,
"Incidentally":1,
"Squamous cell carcinoma":4,
"Tongue cancer":1,
"Research progress":1,
"contrast enhanced ultrasound (CEUS)":1,
"primary squamous cell carcinoma":1,
"thyroid nodules (TNs)":1,
"thyroid ultrasound (US)":1,
"X-ray computed":1,
"sarcomatoid carcinoma":1,
"stomach":1,
"tomography":1,
"Extrapulmonary small cell carcinoma":1,
"external auditory canal":1,
"thyroid transcription factor 1":1,
"AP-1":1,
"JAZF1":1,
"TFAP2B":1,
"Neoplasm staging":2,
"Cancer incidence":1,
"Cancer mortality":1,
"Digital radiography":1,
"Effective dose":1,
"Lifetime attributable risk":1,
"Organ dose":1,
"CD26":1,
"CCDC6-RET":1,
"KIF5B-RET":1,
"RET inhibitor":1,
"Structure-activity relationship":1,
"DICER1":1,
"disease-modifying therapy":1,
"human herpesvirus 4":1,
"interferon β-1b":1,
"thyroid collision tumors":1,
"FHL1 protein, human":1,
"Neoplasm metastasis":1,
"differentially expressed proteins":1,
"invasiveness":1,
"markers":1,
"tandem-mass tag":1,
"infrequent metastatic sites":1,
"long survival":1,
"subcutaneous metastasis":1,
"FBXW":1,
"gene amplification":1,
"mCRPC":1,
"Contralateral occult carcinoma":1,
"multifocality":1,
"metabolism":2,
"tumor associated macrophages":1,
"tumor microenvironment (TME)":1,
"G protein-coupled estrogen receptor":1,
"GPER":1,
"GPR30":1,
"estrogen":1,
"female reproductive cancers":1,
"Giant cells":1,
"Pleomorphic carcinoma":1,
"Undifferentiated":1,
"fluorodeoxyglucose F18":1,
"positron emission tomography":1,
"lymph node":5,
"ThyraMIR":1,
"medullary thyroid cancer (MTC)":1,
"microRNA (miRNA)":1,
"EPIC":1,
"nested case–control study":1,
"polyphenol":1,
"local recurrence":1,
"flow cytometry":1,
"papillary carcinoma":4,
"xenografted mice":1,
"lymph node excision":1,
"lymph nodes":1,
"Depth of invasion":1,
"Head and neck":1,
"Mouth":1,
"hypocalcaemia":1,
"recurrent laryngeal nerve paralysis":1,
"SNP":1,
"VDBP":1,
"[25(OH)D]":1,
"single nucleotide polymorphism":1,
"vitamin D":1,
"vitamin D binding protein":1,
"IMRT":1,
"VMAT":1,
"flattening filter free":1,
"localized prostate cancer":1,
"secondary malignancy risk":1,
"Long non-coding RNA (lncRNA)":1,
"anaplastic":2,
"classical variant papillary thyroid carcinoma":1,
"nuclear medicine":2,
"radioactive iodine":2,
"remnant ablation":1,
"Aspiration cytology":1,
"Mair's score":1,
"fine-needle aspiration cytology":1,
"nonaspiration":1,
"pneumothorax":1,
"targeted molecular therapy":1,
"Rearranged during Transfection (RET)":1,
"Sporadic medullary thyroid carcinoma (MTC)":1,
"genetic alteration":1,
"immune microenvironment":1,
"multikinase inhibitor":1,
"targeting therapy":1,
"Thailand":1,
"immunohistochemistry (IHC)":1,
"tissue microarray":1,
"katanin P60":1,
"katanin P80":1,
"tumor stage":1,
"clinical management":1,
"endocrine pathology":1,
"molecular marker":1,
"telomerase reverse transcriptase expression":1,
"telomerase reverse transcriptase hypermethylation":1,
"telomerase reverse transcriptase promoter mutation":1,
"99mTc-pertechnetate":1,
"salivary gland dynamic scintigraphy":1,
"Iran":2,
"central neck lymph nodes":1,
"disease-free survival":1,
"encapsulated follicular variant of papillary thyroid carcinoma":2,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"pediatric":1,
"Colon adenocarcinoma":1,
"Adenocarcinoma of lung":1,
"Diffuse sclerosing variant of papillary thyroid carcinoma":1,
"Napsin A":1,
"Occult cancer":1,
"Promoter":1,
"TERT":3,
"Extracellular acidification rate":1,
"Pancreatic cancer":1,
"TWIST1":1,
"Warburg effect":1,
"Transthyretin":1,
"endocytosis":1,
"epidermoid carcinoma":1,
"membrane receptors":1,
"prealbumin":1,
"transferrin":1,
"guideline adherence":1,
"quality improvement":1,
"Gene rearrangement":1,
"Humans":1,
"Sarcoma, alveolar soft part":1,
"mass spectrometry":1,
"site-specific N-glycopeptide":1,
"Extensive venous invasion":1,
"Internal jugular vein":1,
"Staged surgical approach":1,
"Superior vena cava":1,
"Tumor thrombus in the atrium":1,
"Esophagus":1,
"Gastric":1,
"Gastroesophageal":1,
"Thyroxine":1,
"recur":1,
"Preoperative":1,
"Thyroid-stimulating hormone":1,
"DCAF16":1,
"IHC":1,
"adenocarcinoma":1,
"basal cell carcinoma":1,
"calvarium invasion":1,
"diploic space invasion":1,
"radiographic imaging":1,
"scalp invasion":1,
"Multinodular goiter":1,
"Solitary thyroid nodule":1,
"Cervical lymph node":1,
"Intermediate risk":1,
"Predictive factors":2,
"PSMD10":1,
"miR-214-3p":1,
"Kidney failure, chronic":1,
"Neoplasms":2,
"Renal dialysis":1,
"L-GILZ":1,
"MAPK":1,
"MAPK pathway–inhibiting drugs":1,
"NF-κB":1,
"RAS mutation":1,
"MUC5AC":1,
"heterogeneity":1,
"lung adenocarcinoma with mucin production":1,
"18F-FDG PET/CT":2,
"Elderly, ultrasonography risk stratification systems":1,
"TCF1":1,
"m6A":1,
"methyltransferase METTL3":1,
"Angioinvasion":1,
"Vascular invasion":1,
"Hyperparathyroidism":1,
"Therapeutic outcomes":1,
"Medullary carcinoma":1,
"ATP binding cassette subfamily D member 3":1,
"Gene Expression Omnibus":1,
"bioinformatics analysis":1,
"colorectal carcinoma":1,
"Cruciferous vegetables":1,
"Glucosinolates":1,
"Glutathione S-transferase polymorphisms":1,
"Isothiocyanates":1,
"iodine 131":1,
"whole-body scintigraphy":1,
"papillary thyroid carcinoma (PTC), miRNA":1,
"Crowdfunding":1,
"Social media":1,
"Thyroid surgery":2,
"Blood flow signal":1,
"Maximum value of elastic modulus":1,
"Scoring system":1,
"Iodine radioisotopes":1,
"Prognoses":1,
"TNM staging systems":1,
"aggressive thyroid cancer":1,
"stair-step procedure":1,
"tracheal resection":3,
"tracheoesophageal invasion":1,
"PDOX":1,
"cisplatinum":1,
"eribulin":1,
"matrix-producing breast carcinoma":1,
"patient-derived orthotopic xenograft":1,
"triple-negative breast cancer":1,
"tumor regression":1,
"axillary lymph node metastasis":1,
"breast invasive ductal carcinoma":1,
"conventional ultrasound":1,
"doubling time":1,
"Neuropilin":1,
"FDG":2,
"PET-CT":1,
"Staging":1,
"Adrenal sparing surgery":1,
"Adrenalectomy":1,
"Pheochromocytoma":2,
"TETs":1,
"American Joint Committee on Cancer (AJCC)":1,
"Follicular variant of papillary thyroid carcinoma (FVPTC)":1,
"Surveillance, Epidemiology, and End Results (SEER)":1,
"staging system":1,
"invasive ductal breast cancer":1,
"neurofibromatosis 1":1,
"Colon Cancer":1,
"HCC":2,
"Metabolic Syndrome":1,
"Smoking":1,
"BRAF V600E":1,
"Indolent":1,
"Bethesda":1,
"Fine needle aspiration (FNA)":1,
"central neck dissection":2,
"follicular neoplasia":1,
"Thyroseq":2,
"indeterminate thyroid nodules":2,
"Gross extrathyroidal extension":1,
"Tumor-node-metastasis staging system":1,
"Papillary thyroid carcinoma follicular thyroid carcinoma":1,
"Pediatric thyroid surgery":1,
"FNAC":1,
"TI-RADS":1,
"Multiple parathyroid adenoma":1,
"cost-effectiveness":1,
"economic evaluation":1,
"laryngoscopy":1,
"vocal fold paralysis":1,
"M2-like tumor-associated macrophages":1,
"Wnt/β-catenin pathway":1,
"Zoledronic acid (ZA)":1,
"Morbidity":3,
"Neuromonitoring":1,
"Recurrent laryngeal nerve":1,
"TOETVA":1,
"Transoral endoscopic thyroidectomy vestibular approach":1,
"Pandemic":1,
"SARS-CoV-2":2,
"Compression symptoms":1,
"Fine needle aspiration cytology":2,
"Operative indications":1,
"Forecasting":1,
"cervical disc surgery":1,
"neck lymphatic metastasis":1,
"occult thyroid carcinoma":1,
"Multiple endocrine neoplasia 2B":1,
"Multiple mucosal neuroma":1,
"Proto-oncogene":1,
"antecedents of other diseases":1,
"cytologic features":1,
"relative prevalence of Hurthle cell cancer":1,
"risk levels":1,
"thyroid cancer histotypes":1,
"primary health care":1,
"Oncocytic":1,
"Postoperative Nonstimulated Thyroglobulin":1,
"Balance":1,
"Dysphonia":1,
"Posturographic analysis":1,
"Stabilometric":1,
"Vocal disorders":1,
"gene":1,
"retrotransposon Gag like 4":1,
"chromosomes":1,
"genes, neoplasm":1,
"suprahyoid retropharyngeal lymph node":1,
"transcervical dissection":1,
"fine needle aspiration parathyroid":1,
"intrathyroidal parathyroid carcinoma":1,
"intrathyroidal parathyroid lesions":1,
"parathyroid cytology":1,
"PLEKHS1":1,
"prognostic factors":1,
"promoter mutations":1,
"lymphovascular invasion":1,
"false positive":1,
"mucinous adenocarcinoma":1,
"ovary":2,
"Multicentric":1,
"99m Tc-octreotide scintigraphy":1,
"whole-body iodine":1,
"mRNAs":1,
"GAS5":1,
"therapeutic targe":1,
"tumor suppressor gene":1,
"remote‐access thyroidectomy":1,
"robotic thyroidectomy":1,
"selective neck dissection":1,
"Carcinoma":4,
"Drug therapy":1,
"Multidetector computed tomography":1,
"Pancreatic ductal":1,
"Treatment outcome":2,
"Cancer stem-like cells":1,
"Metastatic thyroid carcinoma":1,
"Regenerative potential":1,
"Single-cell RNA sequencing":1,
"Thyroid follicular epithelial cells":1,
"Liver X receptors":1,
"Obesity":1,
"Ribosomes":1,
"cause of death":1,
"clinical course":1,
"well-differentiated thyroid cancer":1,
"Graves' disease":1,
"Asia-Pacific":1,
"sensitivity and specificity":1,
"neck ultrasound":1,
"surgeon-performed ultrasound":1,
"fine needle":1,
"large-core needle":1,
"China":1,
"Covid19":1,
"Italy":1,
"Recurrent laryngeal nerve palsy":1,
"Surgical practice":1,
"Genitourinary":1,
"papillary carcinoma of thyroid":1,
"8505C cell line":1,
"BCPAP cell line":1,
"CFLAR":1,
"IL6":1,
"SPINT2":1,
"oxidative phosphorylation":1,
"thyroid hormone synthesis":1,
"weighted pathway regulation":1,
"regulatory network":1,
"collagen capsule":1,
"quantitative analysis":1,
"second harmonic generation microscopy":1,
"Chronic lymphocytic thyroiditis":1,
"N-stage":1,
"Synergistic effects":1,
"tumour-to-tumour metastasis":1,
"ATC":1,
"hypofractionated":1,
"irradiation":1,
"miR-146b":1,
"miR-181b":1,
"miR-21":1,
"miR-221":1,
"miR-222":1,
"plasma":1,
"CD73":1,
"ecto-5′-nucleotidase":1,
"inflammation":1,
"DLEU1":1,
"ROCK1":1,
"miR-421":1,
"robotic surgical procedures":1,
"Discoloration":1,
"Tetracycline":1,
"Head and neck carcinoma":1,
"Maxillary sinus":1,
"Merkel cell carcinoma":1,
"Merkel cell polyomavirus":1,
"Nasal cavity":1,
"AJCC staging":1,
"TCGA data":1,
"Granular cell tumor":1,
"Infundibulum":1,
"Pituicytoma":1,
"Pituitary":1,
"Pituitary ependymoma":1,
"Posterior pituitary":1,
"Posterior pituitary tumors":1,
"Sellar ependymoma":1,
"Spindle cell oncocytoma":1,
"Data set":1,
"ICCR":1,
"Protocol":1,
"Structured report":1,
"Synoptic report":1,
"FUS":1,
"LINC00893":1,
"PTEN/AKT pathway":1,
"differential":1,
"medullary":1,
"Immune Escape":1,
"MHC-II":1,
"Ectopic thyroid tissue":1,
"Follicular adenoma":1,
"Thoracoscopic surgery":1,
"metabolic networks and pathways":1,
"neuroblastoma":1,
"tumor microenvironment":1,
"fine needle biopsy":1,
"Clinical trial":1,
"Healthcare disparities":1,
"Sex":1,
"Age-dependent tumor progression":1,
"Genetic risk":1,
"Germline mutation":1,
"modified radical neck dissection":1,
"postoperative chylothorax":1,
"postoperative complication":1,
"Head and neck cancers":1,
"Long noncoding RNAs":1,
"Receiver operating characteristic":1,
"Serum biomarker":1,
"Epigenomics":1,
"Genomics":1,
"Telomerase":1,
"Progression-free survival":1,
"Protein kinase inhibitors":1,
"Toxicity":1,
"systematic review":1,
"tracheal invasion":1,
"FOXE1":1,
"Systems biology":1,
"WGCNA":1,
"compound mutation":1,
"hereditary medullary thyroid carcinoma":1,
"Ablation techniques":1,
"consensus":1,
"nodular goiter":1,
"ultrasound signal":1,
"clinical N0":1,
"Hepatobiliary":1,
"Japan Association of Endocrine Surgery":1,
"active surveillance":1,
"indications":1,
"strategy":1,
"task force consensus statements":1,
"breast metastasis":1,
"core biopsy":1,
"Health behavior":1,
"Sublingual and vestibular approach":1,
"endoscope assisted":1,
"papillarycarcinoma":1,
"autoimmune disease":1,
"mg and autoimmune diseases":1,
"mg and graves disease":1,
"myasthenia crisis":1,
"myasthenia gravis (mg)":1,
"myasthenia gravis and thyroid disease":1,
"myopathy":1,
"thymectomy":1,
"computer-aided system":1,
"Neo-adjuvant chemotherapy":1,
"Omitting surgery":1,
"Pathological complete response":1,
"chimeric antigen receptor T-cells":1,
"EMT":1,
"long non-coding RNAs":1,
"miR-375":1,
"DEGs":1,
"qiagen RT2 profiler PCR arrays":1,
"signal pathways":1,
"IU1":1,
"MDM2":1,
"UPS":1,
"USP14":1,
"cervical cancer":1,
"parapharyngeal metastasis":1,
"unknown primary":1,
"cell apoptosis":1,
"genistein":1,
"5P strategies":1,
"precision medicine":1,
"Miliary mottling":1,
"tuberculosis":1,
"Cancer genetics":1,
"Cancer screening":1,
"Cowden syndrome":1,
"PTEN mutation":1,
"Clinically node negative":1,
"Contralateral central compartment":1,
"strap muscle invasion":1,
"dosimetry parameters":1,
"predicting model":1,
"complication":1,
"microwave":1,
"radiofrequency":1,
"Survival period":1,
"Electrochemotherapy":1,
"rare non-melanoma skin cancer":1,
"MMP2":1,
"PI3K/AKT":1,
"Rab40b":1,
"cyclins":1,
"radioactive iodine refractory (RAIR)":1,
"malignant struma ovarii":1,
"Early glottic carcinoma":1,
"anterior commissure":1,
"thyroid cartilage":1,
"transoral laser microsurgery":1,
"window technique":1,
"thyroid neoplasms/surgery":1,
"thyroidectomy/methods":1,
"neuroendocrine neoplasm":1,
"peptide receptor radionuclide therapy":1,
"somatostatin analogues":1,
"AXL":1,
"CAR T":1,
"FET":1,
"FLT":1,
"PSMA":1,
"Theranostics":1,
"lung metastasis":1,
"mIBG":1,
"non-small cell lung cancer (NSCLC)":1,
"positron emission tomography (PET)":1,
"small cell lung cancer (SCLC)":1,
"thoracic adenopathy":1,
"gender differences":1,
"gross":1,
"indicator":1,
"regional characteristics":1,
"standardized":1,
"tumor progression model":1,
"Correlation":1,
"Radioactive iodine (RAI)":1,
"outpatient-based ablation":1,
"risk classification":1,
"GAS8-AS1":1,
"Thyroid abscess":1,
"clinical":1,
"imaging":1,
"cytochrome P450":1,
"cytochrome b5":1,
"FATWO":1,
"cytohistology":1,
"mesonephric":1,
"Bmi1":1,
"Ink4A/Arf":1,
"Intrahepatic cholangiocarcinoma":1,
"Frozen section":1,
"Lateral neck metastasis":1,
"well‐differentiated thyroid carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年第3季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
